1. Synthesis of 2-deoxy-2,2-difluoro-d-ribose and 2-deoxy-2,2-dinuoro-d-ribofuranosyl nucleosides;Hertel;J Org Chem,1988
2. Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer;Braakhuis;Cancer Res,1991
3. Pharmacokinetics of Gemcitabine (LY 188011; difluo-rodeoxycytidine) administered every two weeks in a Phase I study;Peters,1990
4. Evaluation of the antitumor activity of Gemcitabine (2',2'-difluoro-deoxycytidine);Hertel;Cancer Res,1990
5. A phase II study of Gemcitabine in non-small cell lung cancer (NSCLC) using a twice weekly schedule;Lund,1992